Aneuploidogenic effects and DNA oxidation induced in vitro by differently sized gold nanoparticles

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2191-2204

  Di Bucchianico, Sebastiano ^a   Fabbrizi, Maria Rita ^a   Cirillo, Silvia ^a   Uboldi, Chiara ^a   Gilliland, Douglas ^b   Valsami Jones, Eugenia ^c,d   Migliore, Lucia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b JOINT RESEARCH CENTRE   (Italy)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

Author keywords

Aneuploidy; Au nanoparticles; Cytotoxicity; Micronuclei; Oxidative DNA damage; Particle size

Indexed keywords

GOLD NANOPARTICLE; ANEUGEN; GOLD; METAL NANOPARTICLE;

ANEUPLOIDY; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME DAMAGE; CHROMOSOME SEGREGATION; COMET ASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DNA DAMAGE; DNA STRAND BREAKAGE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICRONUCLEUS TEST; MITOSIS INHIBITION; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PARTICLE SIZE; ANIMAL; CHEMICALLY INDUCED; CHROMOSOME ABERRATION; DRUG EFFECTS; MACROPHAGE; MATERIALS TESTING; MOUSE; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANEUGENS; ANEUPLOIDY; ANIMALS; CHROMOSOME ABERRATIONS; DNA DAMAGE; GOLD; HUMANS; MACROPHAGES; MATERIALS TESTING; METAL NANOPARTICLES; MICE; OXIDATION-REDUCTION; PARTICLE SIZE;

EID: 84900391680     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S58397     Document Type: Article

References (53)

1. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6(4):662-668.
2. Chithrani BD, Chan WC. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007;7(6):1542-1550.
3. Gao H, Shi W, Freund LB. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 2005;102(27):9469-9474.
4. Vetten MA, Tlotleng N, Tanner Rascher D, et al. Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines. Part Fibre Toxicol. 2013;10:50.
5. Greulich C, Diendorf J, Gessmann J, et al. Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta Biomater. 2011;7(9):3505-3514.
6. Uboldi C, Bonacchi D, Lorenzi G, et al. Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441. Part Fibre Toxicol. 2009;6:18.
7. Freese C, Uboldi C, Gibson MI, et al. Uptake and cytotoxicity of citrate-coated gold nanospheres: Comparative studies on human endothelial and epithelial cells. Part Fibre Toxicol. 2012;9:23.
8. Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, Riviere JE. Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett. 2013;220(3):286-293.
9. Cedervall T, Lynch I, Lindman S, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A. 2007;104(7): 2050-2055.
10. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev. 2012;41(6): 2256-2282.
11. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1(11): 845-867.
12. Deng ZJ, Liang M, Toth I, Monteiro M, Minchin RF. Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology. 2013;7(3):314-322.
13. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc. 2012;134(4):2139-2147.
14. Hirn S, Semmler-Behnke M, Schleh C, et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm. 2011;77(3): 407-416.
15. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces. 2008;66(2):274-280.
16. Abdelhalim MA, Jarrar BM. Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver. Lipids Health Dis. 2011;10:166.
17. Gosens I, Post JA, de la Fonteyne LJ, et al. Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation. Part Fibre Toxicol. 2010;7(1):37.
18. Vecchio G, Galeone A, Brunetti V, et al. Concentration-dependent, size-independent toxicity of citrate capped AuNPs in Drosophila melanogaster. PLoS One. 2012;7(1):e29980.
19. Pan JF, Buffet PE, Poirier L, et al. Size dependent bioaccumulation and ecotoxicity of gold nanoparticles in an endobenthic invertebrate: the Tellinid clam Scrobicularia plana. Environ Pollut. 2012;168:37-43.
20. Coradeghini R, Gioria S, García CP, et al. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol Lett. 2013;217(3):205-216.
21. Migliore L, Frenzilli G, Nesti C, Fortaner S, Sabbioni E. Cytogenetic and oxidative damage induced in human lymphocytes by platinum, rhodium and palladium compounds. Mutagenesis. 2002;17(5):411-417.
22. Migliore L, Saracino D, Bonelli A, et al. Carbon nanotubes induce oxidative DNA damage in RAW264.7 cells. Environ Mol Mutagen. 2010;51(4):294-303.
23. Fenech, M. Cytokinesis-block micronucleus cytome assay. Nat Protoc. 2007;2(5):1084-1104.
24. Di Bucchianico S, Fabbrizi MR, Misra SK, et al. Multiple cytotoxic and genotoxic effects induced in vitro by differently shaped copper oxide nanomaterials. Mutagenesis. 2013;28(3):287-299.
25. Kroll A, Pillukat MH, Hahn D, Schnekenburger J. Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol. 2012;86(7):1123-1136.
26. Patra HK, Banerjee S, Chaudhuri U, Lahiri P, Dasgupta AK. Cell selective response to gold nanoparticles. Nanomedicine. 2007;3(2): 111-119.
27. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40(4):328-346.
28. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces. 2008;66(2):274-280.
29. Vecchio G, Galeone A, Brunetti V, et al. Mutagenic effects of gold nanoparticles induce aberrant phenotypes in Drosophila melanogaster. Nanomedicine. 2012;8(1):1-7.
30. Smith MR, Boenzli MG, Hindagolla V, et al. Identification of gold nanoparticle-resistant mutants of Saccharomyces cerevisiae suggests a role for respiratory metabolism in mediating toxicity. Appl Environ Microbiol. 2013;79(2):728-733.
31. Elbakry A, Wurster EC, Zaky A, et al. Layer-by-layer coated gold nanoparticles: size-dependent delivery of DNA into cells. Small. 2012;8(24):3847-3856.
32. Oh E, Delehanty JB, Sapsford KE, et al. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. ACS Nano. 2011;5(8):6434-6448.
33. Li JJ, Zou L, Hartono D, Ong CN, Bay BH, Lanry Yung LY. Gold Nanoparticles Induce Oxidative Damage in Lung Fibroblasts In Vitro. Adv Mater. 2008;20(1):138-142.
34. Sumbayev VV, Yasinska IM, Garcia CP, et al. Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses. Small. 2013;9(3):472-477.
35. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E. The role of nanoparticle size in hemocompatibility. Toxicology. 2009;258(2-3):139-147.
36. Love SA, Thompson JW, Haynes CL. Development of screening assays for nanoparticle toxicity assessment in human blood: preliminary studies with charged Au nanoparticles. Nanomedicine (Lond). 2012;7(9):1355-1364.
37. Zhang XD, Wu D, Shen X, et al. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomedicine. 2011;6: 2071-2081.
38. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622-627.
39. Papageorgiou I, Brown C, Schins R, et al. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials. 2007;28(19):2946-2958.
40. Schaeublin NM, Braydich-Stolle LK, Schrand AM, et al. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale. 2011;3(2):410-420.
41. Thomas P, Umegaki K, Fenech M. Nucleoplasmic bridges are a sensitive measure of chromosome rearrangement in the cytokinesis-block micronucleus assay. Mutagenesis. 2003;18(2):187-194.
42. Schulz M, Ma-Hock L, Brill S, et al. Investigation on the genotoxicity of different sizes of gold nanoparticles administered to the lungs of rats. Mutat Res. 2012;745(1-2):51-57.
43. Downs TR, Crosby ME, Hu T, et al. Silica nanoparticles administered at the maximum tolerated dose induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. Mutat Res. 2012;745(1-2):38-50.
44. Paino IM, Marangoni VS, de Oliveira Rde C, Antunes LM, Zucolotto V. Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells. Toxicol Lett. 2012;215(2):119-125.
45. Geffroy B, Ladhar C, Cambier S, Treguer-Delapierre M, Brèthes D, Bourdineaud JP. Impact of dietary gold nanoparticles in zebrafish at very low contamination pressure: the role of size, concentration and exposure time. Nanotoxicology. 2012;6(2):144-160.
46. Choi SY, Jeong S, Jang SH, et al. In vitro toxicity of serum protein-adsorbed citrate-reduced gold nanoparticles in human lung adenocarcinoma cells. Toxicol In Vitro. 2012;26(2):229-237.
47. Di Guglielmo C, De Lapuente J, Porredon C, Ramos-López D, Sendra J, Borràs M. In vitro safety toxicology data for evaluation of gold nanoparticles-chronic cytotoxicity, genotoxicity and uptake. J Nanosci Nanotechnol. 2012;12(8):6185-6191.
48. Li JJ, Lo SL, Ng CT, et al. Genomic instability of gold nanoparticle treated human lung fibroblast cells. Biomaterials. 2011;32(23): 5515-5523.
49. Herrera LA, Prada D, Andonegui MA, Dueñas-González A. The epigenetic origin of aneuploidy. Curr Genomics. 2008;9(1):43-50.
50. Inglot P, Lewinska A, Potocki L, et al. Cadmium-induced changes in genomic DNA-methylation status increase aneuploidy events in a pig Robertsonian translocation model. Mutat Res. 2012;747(2): 182-189.
51. Yang Y, Qu Y, Lü X. Global gene expression analysis of the effects of gold nanoparticles on human dermal fibroblasts. J Biomed Nanotechnol. 2010;6(3):234-246.
52. Ng CT, Dheen ST, Yip WC, Ong CN, Bay BH, Lanry Yung LY. The induction of epigenetic regulation of PROS1 gene in lung fibroblasts by gold nanoparticles and implications for potential lung injury. Biomaterials. 2011;32(30):7609-7615.
53. Stoccoro A, Karlsson HL, Coppedè F, Migliore L. Epigenetic effects of nano-sized materials. Toxicology. 2013;313(1):3-14.